These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 141623)

  • 1. Lack of involvement of dopaminergic and GABA neurones in the inhbitory effect of harmaline on the activity of striatal cholinergic neurones in the rat.
    Javoy F; Euvrard C; Herbet A; Bockaert J; Enjalbert A; Agid Y; Glowinski J
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Apr; 297(3):233-9. PubMed ID: 141623
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional interaction between rat substantia nigra and striatum: GABA and dopamine interrelation.
    Racagni G; Bruno F; Cattabeni F; Maggi A; Di Giulio AM; Parenti M; Groppetti A
    Brain Res; 1977 Oct; 134(2):353-8. PubMed ID: 890495
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of quipazine, a serotonin-like drug, on striatal cholinergic interneurones.
    Euvrard C; Javoy F; Herbet A; Glowinski J
    Eur J Pharmacol; 1977 Feb; 41(3):281-9. PubMed ID: 138594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The striatal dopaminergic function is mediated by the inhibition of a nigral, non-dopaminergic neuronal system via a strio-nigral GABAergic pathway.
    Olianas MC; De Montis GM; Mulas G; Tagliamonte A
    Eur J Pharmacol; 1978 Jun; 49(3):233-41. PubMed ID: 566207
    [No Abstract]   [Full Text] [Related]  

  • 5. Gabaergic processes involved in the control of dopamine release from nigrostriatal dopaminergic neurons in the cat.
    Chéramy A; Nieoullon A; Glowinski J
    Eur J Pharmacol; 1978 Apr; 48(3):281-95. PubMed ID: 639856
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
    Nissbrandt H; Engberg G; Pileblad E
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic, GABA-ergic and cholinergic interaction in the regulation of striatal acetylcholine concentration.
    Sethy VH
    Res Commun Chem Pathol Pharmacol; 1978 Aug; 21(2):359-62. PubMed ID: 358340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotational behaviour and striatal dopamine metabolism following unilateral activation of nigral GABA mechanisms: GABA-like modulation of dopaminergic and non-dopaminergic neurons in rat substantia nigra [proceedings].
    Waddington JL
    Br J Pharmacol; 1978 Jun; 63(2):384P. PubMed ID: 566600
    [No Abstract]   [Full Text] [Related]  

  • 9. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo.
    Paladini CA; Celada P; Tepper JM
    Neuroscience; 1999 Mar; 89(3):799-812. PubMed ID: 10199614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic involvement in hypothalamic function: extrahypothalamic and hypothalamic control. A neuroanatomical analysis.
    Fuxe K; Goldstein M; Hökfelt T; Jonsson G; Lidbrink P
    Adv Neurol; 1974; 5():405-19. PubMed ID: 4374065
    [No Abstract]   [Full Text] [Related]  

  • 11. Interactions between GABA, dopamine, acetylcholine, and glutamate-containing neurons in the extrapyramidal and limbic systems.
    Bartholini G; Scatton B; Worms P; Zivkovic B; Lloyd KG
    Adv Biochem Psychopharmacol; 1981; 30():119-28. PubMed ID: 6120626
    [No Abstract]   [Full Text] [Related]  

  • 12. Transmitters for the afferent and efferent systems of the neostriatum and their possible interactions.
    Kim JS
    Adv Biochem Psychopharmacol; 1978; 19():217-33. PubMed ID: 29447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory influence of the nigrostriatal dopamine system on the striatal cholinergic neurons in the rat.
    Agid Y; Guyenet P; Glowinski J; Beaujouan JC; Javoy F
    Brain Res; 1975 Mar; 86(3):488-92. PubMed ID: 1116013
    [No Abstract]   [Full Text] [Related]  

  • 14. Serotoninergic modulation of mesolimbic and frontal cortical dopamine neurons.
    Waldmeier PC
    Experientia; 1980 Sep; 36(9):1092-4. PubMed ID: 6448165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociable properties of dopamine neurons im the nigrostriatal and mesolimbic dopamine systems.
    Koob GF; Del Fiacco M; Iversen SD
    Adv Biochem Psychopharmacol; 1977; 16():589-95. PubMed ID: 560793
    [No Abstract]   [Full Text] [Related]  

  • 16. Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
    Maggi A; Bruno F; Cattabeni F; Groppetti A; Parenti M; Racagni G
    Brain Res; 1978 Apr; 145(1):180-4. PubMed ID: 205324
    [No Abstract]   [Full Text] [Related]  

  • 17. Involvement of the dopamine nigrostriatal system in the picrotoxin effect on striatal acetylcholine levels.
    Javoy F; Euvrard C; Herbet A; Glowinski J
    Brain Res; 1977 May; 126(2):382-6. PubMed ID: 861728
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of neurotensin and immunneutralization with anti-neurotensin-serum on dopaminergic-cholinergic interaction in the striatum.
    Töröcsik A; Rakovska A; Görcs T; Vizi ES
    Brain Res; 1993 May; 612(1-2):306-12. PubMed ID: 8101133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amantadine actions on acetylcholine and GABA in striatum and substantia nigra of rat in relation to behavioral changes.
    Bak IJ; Hassler R; Kim JS; Kataoka K
    J Neural Transm; 1972; 33(1):45-61. PubMed ID: 4674484
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction between GABA agonists and the cholinergic muscarinic system in rat corpus striatum.
    Ferkany JW; Enna SJ
    Life Sci; 1980 Jul; 27(2):143-9. PubMed ID: 7401929
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.